Allogene Therapeutics
ALLO
#8751
Rank
C$0.31 B
Marketcap
C$0.90
Share price
-5.88%
Change (1 day)
-48.10%
Change (1 year)

EPS for Allogene Therapeutics (ALLO)

EPS in 2026 (TTM): C-$0.93

According to Allogene Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$0.96. In 2025 the company made an earnings per share (EPS) of C-$1.25 an increase over its 2024 EPS that were of C-$1.91.

EPS history for Allogene Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.93-25.28%
2025C-$1.25-34.59%
2024C-$1.91
2022C-$3.3322.75%
2021C-$2.71-9.13%
2020C-$2.9814.92%
2019C-$2.60-9.42%
2018C-$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94 101.49%๐Ÿ‡บ๐Ÿ‡ธ USA